Var2 Pharmaceuticals Aps
Overview
VAR2 Pharmaceuticals ApS is a clinical-stage biotechnology company based in Copenhagen, Denmark, specializing in the development of first-in-class therapeutics targeting oncofetal chondroitin sulfate, a tumor-specific glycosaminoglycan. Founded in 2012, the company focuses on creating novel cancer treatments, particularly for hard-to-treat, recurrent, and metastatic cancers.
Therapeutic areas
Oncofetal Chondroitin SulfateCancer ImmunotherapyAntibody-Drug Conjugates
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Var2 Pharmaceuticals Aps in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.